ID   TYRO_HUMAN              Reviewed;         529 AA.
AC   P14679; Q15675; Q15676; Q15680; Q8TAK4; Q9BYY0; Q9BZX1;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 3.
DT   10-MAY-2017, entry version 195.
DE   RecName: Full=Tyrosinase;
DE            EC=1.14.18.1;
DE   AltName: Full=LB24-AB;
DE   AltName: Full=Monophenol monooxygenase;
DE   AltName: Full=SK29-AB;
DE   AltName: Full=Tumor rejection antigen AB;
DE   Flags: Precursor;
GN   Name=TYR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=1903356; DOI=10.1016/0888-7543(91)90409-8;
RA   Giebel L.B., Strunk K.M., Spritz R.A.;
RT   "Organization and nucleotide sequences of the human tyrosinase gene
RT   and a truncated tyrosinase-related segment.";
RL   Genomics 9:435-445(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2823263; DOI=10.1073/pnas.84.21.7473;
RA   Kwon B.S., Haq A.K., Pomerantz S.H., Halaban R.;
RT   "Isolation and sequence of a cDNA clone for human tyrosinase that maps
RT   at the mouse c-albino locus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:7473-7477(1987).
RN   [3]
RP   ERRATUM, AND SEQUENCE REVISION TO 384-398.
RA   Kwon B.S., Haq A.K., Pomerantz S.H., Halaban R.;
RL   Proc. Natl. Acad. Sci. U.S.A. 85:6352-6352(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Melanoma;
RX   PubMed=2499655; DOI=10.1084/jem.169.6.2029;
RA   Bouchard B., Fuller B.B., Vijayasaradhi S., Houghton A.N.;
RT   "Induction of pigmentation in mouse fibroblasts by expression of human
RT   tyrosinase cDNA.";
RL   J. Exp. Med. 169:2029-2042(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1711223; DOI=10.1073/pnas.88.12.5272;
RA   Chintamaneni C.D., Halaban R., Kobayashi Y., Witkop C.J., Kwon B.S.;
RT   "A single base insertion in the putative transmembrane domain of the
RT   tyrosinase gene as a cause for tyrosinase-negative oculocutaneous
RT   albinism.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:5272-5276(1991).
RN   [6]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 1).
RC   TISSUE=Melanoma, and T-cell;
RX   PubMed=8340755; DOI=10.1084/jem.178.2.489;
RA   Brichard V., van Pel A., Woelfel T., Woelfel C., de Plaen E.,
RA   Lethe B.G., Coulie P., Boon T.;
RT   "The tyrosinase gene codes for an antigen recognized by autologous
RT   cytolytic T lymphocytes on HLA-A2 melanomas.";
RL   J. Exp. Med. 178:489-495(1993).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND VARIANT TYR-192.
RX   PubMed=11153699; DOI=10.1034/j.1600-0749.2000.130609.x;
RA   Martinez-Arias R., Comas D., Andres A., Abello M.-T.,
RA   Domingo-Roura X., Bertranpetit J.;
RT   "The tyrosinase gene in gorillas and the albinism of 'Snowflake'.";
RL   Pigment Cell Res. 13:467-470(2000).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-272.
RC   TISSUE=Liver;
RX   PubMed=2480811; DOI=10.1016/0167-4781(89)90115-2;
RA   Kikuchi H., Miura H., Yamamoto H., Takeuchi T., Dei T., Watanabe M.;
RT   "Characteristic sequences in the upstream region of the human
RT   tyrosinase gene.";
RL   Biochim. Biophys. Acta 1009:283-286(1989).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-32.
RX   PubMed=2504160; DOI=10.1016/0006-291X(89)90770-5;
RA   Takeda A., Tomita Y., Okinaga S., Tagami H., Shibahara S.;
RT   "Functional analysis of the cDNA encoding human tyrosinase
RT   precursor.";
RL   Biochem. Biophys. Res. Commun. 162:984-990(1989).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 54-195, AND VARIANT TYR-192.
RX   PubMed=11214319; DOI=10.1038/35054550;
RA   Murphy W.J., Eizirik E., Johnson W.E., Zhang Y.-P., Ryder O.A.,
RA   O'Brien S.J.;
RT   "Molecular phylogenetics and the origins of placental mammals.";
RL   Nature 409:614-618(2001).
RN   [12]
RP   REVIEW ON OCA VARIANTS.
RX   PubMed=8477259; DOI=10.1002/humu.1380020102;
RA   Oetting W.S., King R.A.;
RT   "Molecular basis of type I (tyrosinase-related) oculocutaneous
RT   albinism: mutations and polymorphisms of the human tyrosinase gene.";
RL   Hum. Mutat. 2:1-6(1993).
RN   [13]
RP   REVIEW ON OCA1 VARIANTS.
RX   PubMed=10094567;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:2<99::AID-HUMU2>3.3.CO;2-3;
RA   Oetting W.S., King R.A.;
RT   "Molecular basis of albinism: mutations and polymorphisms of
RT   pigmentation genes associated with albinism.";
RL   Hum. Mutat. 13:99-115(1999).
RN   [14]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=12643545; DOI=10.1021/pr025562r;
RA   Basrur V., Yang F., Kushimoto T., Higashimoto Y., Yasumoto K.,
RA   Valencia J., Muller J., Vieira W.D., Watabe H., Shabanowitz J.,
RA   Hearing V.J., Hunt D.F., Appella E.;
RT   "Proteomic analysis of early melanosomes: identification of novel
RT   melanosomal proteins.";
RL   J. Proteome Res. 2:69-79(2003).
RN   [15]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [16]
RP   VARIANTS OCA1A LYS-373 AND ASN-383, AND VARIANTS TYR-192 AND GLN-402.
RX   PubMed=2342539; DOI=10.1056/NEJM199006143222407;
RA   Spritz R.A., Strunk K.M., Giebel L.B., King R.A.;
RT   "Detection of mutations in the tyrosinase gene in a patient with type
RT   IA oculocutaneous albinism.";
RL   N. Engl. J. Med. 322:1724-1728(1990).
RN   [17]
RP   VARIANT OCA1A LEU-81.
RX   PubMed=1970634; DOI=10.1073/pnas.87.9.3255;
RA   Giebel L.B., Strunk K.M., King R.A., Hanifin J.M., Spritz R.A.;
RT   "A frequent tyrosinase gene mutation in classic, tyrosinase-negative
RT   (type IA) oculocutaneous albinism.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:3255-3258(1990).
RN   [18]
RP   VARIANTS OCA1B PHE-275 AND LEU-406.
RX   PubMed=1903591;
RA   Giebel L.B., Tripathi R.K., Strunk K.M., Hanifin J.M., Jackson C.E.,
RA   King R.A., Spritz R.A.;
RT   "Tyrosinase gene mutations associated with type IB ('yellow')
RT   oculocutaneous albinism.";
RL   Am. J. Hum. Genet. 48:1159-1167(1991).
RN   [19]
RP   ERRATUM.
RA   Giebel L.B., Tripathi R.K., Strunk K.M., Hanifin J.M., Jackson C.E.,
RA   King R.A., Spritz R.A.;
RL   Am. J. Hum. Genet. 49:696-696(1991).
RN   [20]
RP   VARIANTS OCA1A SER-21; TRP-217; HIS-299; SER-403; SER-446 AND ASN-448.
RX   PubMed=1642278; DOI=10.1002/ajmg.1320430523;
RA   Tripathi R.K., Strunk K.M., Giebel L.B., Weleber R.G., Spritz R.A.;
RT   "Tyrosinase gene mutations in type I (tyrosinase-deficient)
RT   oculocutaneous albinism define two clusters of missense
RT   substitutions.";
RL   Am. J. Med. Genet. 43:865-871(1992).
RN   [21]
RP   VARIANT OCA1A ARG-89.
RX   PubMed=1899321;
RA   Spritz R.A., Strunk K.M., Hsieh C.-L., Sekhon G.S., Francke U.;
RT   "Homozygous tyrosinase gene mutation in an American black with
RT   tyrosinase-negative (type IA) oculocutaneous albinism.";
RL   Am. J. Hum. Genet. 48:318-324(1991).
RN   [22]
RP   VARIANT OCA1B GLN-422.
RX   PubMed=1900309; DOI=10.1172/JCI115075;
RA   Giebel L.B., Tripathi R.K., King R.A., Spritz R.A.;
RT   "A tyrosinase gene missense mutation in temperature-sensitive type I
RT   oculocutaneous albinism. A human homologue to the Siamese cat and the
RT   Himalayan mouse.";
RL   J. Clin. Invest. 87:1119-1122(1991).
RN   [23]
RP   VARIANTS OCA1A GLY-42; TYR-55; THR-206 AND ARG-419.
RX   PubMed=1943686;
RA   King R.A., Mentink M.M., Oetting W.S.;
RT   "Non-random distribution of missense mutations within the human
RT   tyrosinase gene in type I (tyrosinase-related) oculocutaneous
RT   albinism.";
RL   Mol. Biol. Med. 8:19-29(1991).
RN   [24]
RP   VARIANTS OCA1A ILE-176 AND GLN-217.
RX   PubMed=1487241; DOI=10.1007/BF00220074;
RA   Oetting W.S., King R.A.;
RT   "Molecular analysis of type I-A (tyrosinase negative) oculocutaneous
RT   albinism.";
RL   Hum. Genet. 90:258-262(1992).
RN   [25]
RP   VARIANTS OCA1A GLN-328; ARG-419 AND LEU-431.
RX   PubMed=7902671;
RA   Tripathi R.K., Bundey S., Musarella M.A., Droetto S., Strunk K.M.,
RA   Holmes S.A., Spritz R.A.;
RT   "Mutations of the tyrosinase gene in Indo-Pakistani patients with type
RT   I (tyrosinase-deficient) oculocutaneous albinism (OCA).";
RL   Am. J. Hum. Genet. 53:1173-1179(1993).
RN   [26]
RP   VARIANTS OCA1A ASP-47; CYS-217 DEL; HIS-299 AND LYS-373, AND VARIANTS
RP   OCA1B SER-152 AND LYS-294.
RX   PubMed=8128955;
RA   Gershoni-Baruch R., Rosenmann A., Droetto S., Holmes S.A.,
RA   Tripathi R.K., Spritz R.A.;
RT   "Mutations of the tyrosinase gene in patients with oculocutaneous
RT   albinism from various ethnic groups in Israel.";
RL   Am. J. Hum. Genet. 54:586-594(1994).
RN   [27]
RP   VARIANTS OCA1A TYR-367; THR-370 AND LYS-373, AND VARIANT GLN-402.
RX   PubMed=7955413; DOI=10.1016/0009-8981(94)90131-7;
RA   Breimer L.H., Winder A.F., Jay B., Jay M.;
RT   "Initiation codon mutation of the tyrosinase gene as a cause of human
RT   albinism.";
RL   Clin. Chim. Acta 227:17-22(1994).
RN   [28]
RP   VARIANTS OCA1A ARG-361 AND TYR-371.
RX   PubMed=8644824; DOI=10.1016/S0002-9394(14)70647-6;
RA   Summers C.G., Oetting W.S., King R.A.;
RT   "Diagnosis of oculocutaneous albinism with molecular analysis.";
RL   Am. J. Ophthalmol. 121:724-726(1996).
RN   [29]
RP   VARIANT GLN-402.
RX   PubMed=9158138; DOI=10.1093/hmg/6.5.659;
RA   Morell R., Spritz R.A., Ho L., Pierpont J., Guo W., Friedman T.B.,
RA   Asher J.H. Jr.;
RT   "Apparent digenic inheritance of Waardenburg syndrome type 2 (WS2) and
RT   autosomal recessive ocular albinism (AROA).";
RL   Hum. Mol. Genet. 6:659-664(1997).
RN   [30]
RP   VARIANTS OCA1A AND OCA1B.
RX   PubMed=9259202;
RX   DOI=10.1002/(SICI)1098-1004(1997)10:2<171::AID-HUMU11>3.0.CO;2-X;
RA   Spritz R.A., Oh J., Fukai K., Holmes S.A., Ho L., Chitayat D.,
RA   France T.D., Musarella M.A., Orlow S.J., Schnur R.E., Weleber R.G.,
RA   Levin A.V.;
RT   "Novel mutations of the tyrosinase (TYR) gene in type I oculocutaneous
RT   albinism (OCA1).";
RL   Hum. Mutat. 10:171-174(1997).
RN   [31]
RP   VARIANTS OCA1A AND OCA1B.
RX   PubMed=10671066;
RX   DOI=10.1002/(SICI)1098-1004(1998)12:6<433::AID-HUMU14>3.3.CO;2-7;
RA   Oetting W.S., Fryer J.P., King R.A.;
RT   "Mutations of the human tyrosinase gene associated with tyrosinase
RT   related oculocutaneous albinism (OCA1).";
RL   Hum. Mutat. 12:433-434(1998).
RN   [32]
RP   ERRATUM.
RA   Oetting W.S., Fryer J.P., King R.A.;
RL   Hum. Mutat. 13:83-83(1999).
RN   [33]
RP   VARIANTS OCA1A TYR-36; GLN-77; TRP-77; LEU-81; ARG-97; GLN-217;
RP   TRP-217; SER-236; CYS-272; ARG-289; GLY-294; LYS-294; PRO-355;
RP   TYR-371; LYS-373; LEU-406; ARG-419; GLN-422; VAL-439; SER-446 AND
RP   ASN-448, VARIANT OCA1B SER-403, AND VARIANTS TYR-192 AND GLN-402.
RX   PubMed=10987646; DOI=10.1007/s004390051090;
RA   Passmore L.A., Kaesmann-Kellner B., Weber B.H.F.;
RT   "Novel and recurrent mutations in the tyrosinase gene and the P gene
RT   in the German albino population.";
RL   Hum. Genet. 105:200-210(1999).
RN   [34]
RP   ERRATUM.
RA   Passmore L.A., Kaesmann-Kellner B., Weber B.H.F.;
RL   Hum. Genet. 108:208-208(2001).
RN   [35]
RP   VARIANTS OCA1A TYR-55; ARG-77 INS; GLY-289; HIS-299; SER-299 AND
RP   LEU-400.
RX   PubMed=10571953;
RX   DOI=10.1002/(SICI)1098-1004(199912)14:6<542::AID-HUMU14>3.0.CO;2-3;
RA   Tsai C.-H., Tsai F.-J., Wu J.-Y., Lin S.-P., Chang J.-G., Yang C.-F.,
RA   Lee C.-C.;
RT   "Insertion/deletion mutations of type I oculocutaneous albinism in
RT   Chinese patients from Taiwan.";
RL   Hum. Mutat. 14:542-542(1999).
RN   [36]
RP   VARIANTS OCA1A ASP-47; GLN-77; ARG-109; THR-205; TYR-256; PHE-275;
RP   LYS-294; GLY-339; PRO-355; LYS-373; ASN-383 AND SER-446.
RX   PubMed=11295837; DOI=10.1002/humu.38;
RA   Camand O., Marchant D., Boutboul S., Pequignot M., Odent S.,
RA   Dollfus H., Sutherland J., Levin A., Menasche M., Marsac C.,
RA   Dufier J.-L., Heon E., Abitbol M.;
RT   "Mutation analysis of the tyrosinase gene in oculocutaneous
RT   albinism.";
RL   Hum. Mutat. 17:352-352(2001).
RN   [37]
RP   VARIANT OCA1A TRP-239.
RX   PubMed=11858948; DOI=10.1016/S0923-1811(01)00141-4;
RA   Nakamura E., Miyamura Y., Matsunaga J., Kano Y., Dakeishi-Hara M.,
RA   Tanita M., Kono M., Tomita Y.;
RT   "A novel mutation of the tyrosinase gene causing oculocutaneous
RT   albinism type 1 (OCA1).";
RL   J. Dermatol. Sci. 28:102-105(2002).
RN   [38]
RP   VARIANTS OCA1A ARG-44; GLY-44; ASP-47; VAL-47; HIS-68; GLN-77; LEU-79;
RP   LEU-81; SER-155; PHE-177; LEU-179; ASN-180; ASN-199; SER-201; SER-217;
RP   LEU-236; VAL-240; THR-243; TYR-256; ARG-289; GLU-318; PRO-329;
RP   THR-332; GLY-345; PRO-355; LYS-373; LYS-378; ASN-383; PHE-393;
RP   ARG-395; VAL-398; ALA-398; LEU-402; SER-403; ASN-404; LEU-405;
RP   LEU-406; HIS-408; ASP-409; SER-416; HIS-417; ARG-419; GLN-422;
RP   PHE-424; LYS-426; GLY-427; ILE-434; ASP-435; GLY-444 AND ASN-448, AND
RP   VARIANTS TYR-192 AND GLN-402.
RX   PubMed=15146472; DOI=10.1002/humu.9248;
RA   Opitz S., Kaesmann-Kellner B., Kaufmann M., Schwinger E., Zuehlke C.;
RT   "Detection of 53 novel DNA variations within the tyrosinase gene and
RT   accumulation of mutations in 17 patients with albinism.";
RL   Hum. Mutat. 23:630-631(2004).
RN   [39]
RP   VARIANT TYR-192, AND ASSOCIATION WITH SHEP3.
RX   PubMed=17999355; DOI=10.1086/522235;
RA   Stokowski R.P., Pant P.V.K., Dadd T., Fereday A., Hinds D.A.,
RA   Jarman C., Filsell W., Ginger R.S., Green M.R., van der Ouderaa F.J.,
RA   Cox D.R.;
RT   "A genomewide association study of skin pigmentation in a South Asian
RT   population.";
RL   Am. J. Hum. Genet. 81:1119-1132(2007).
RN   [40]
RP   VARIANT TYR-192, AND ASSOCIATION WITH SHEP3.
RX   PubMed=17952075; DOI=10.1038/ng.2007.13;
RA   Sulem P., Gudbjartsson D.F., Stacey S.N., Helgason A., Rafnar T.,
RA   Magnusson K.P., Manolescu A., Karason A., Palsson A., Thorleifsson G.,
RA   Jakobsdottir M., Steinberg S., Palsson S., Jonasson F.,
RA   Sigurgeirsson B., Thorisdottir K., Ragnarsson R.,
RA   Benediktsdottir K.R., Aben K.K., Kiemeney L.A., Olafsson J.H.,
RA   Gulcher J., Kong A., Thorsteinsdottir U., Stefansson K.;
RT   "Genetic determinants of hair, eye and skin pigmentation in
RT   Europeans.";
RL   Nat. Genet. 39:1443-1452(2007).
RN   [41]
RP   VARIANT OCA1A TYR-91.
RX   PubMed=22981120; DOI=10.1016/j.ajhg.2012.08.007;
RA   Chong J.X., Ouwenga R., Anderson R.L., Waggoner D.J., Ober C.;
RT   "A population-based study of autosomal-recessive disease-causing
RT   mutations in a founder population.";
RL   Am. J. Hum. Genet. 91:608-620(2012).
RN   [42]
RP   VARIANTS OCA1A LEU-50; TRP-77; PHE-275; TRP-298; VAL-355; HIS-364;
RP   LYS-373; ALA-384 AND ASP-490.
RX   PubMed=23504663; DOI=10.1002/humu.22315;
RA   Simeonov D.R., Wang X., Wang C., Sergeev Y., Dolinska M., Bower M.,
RA   Fischer R., Winer D., Dubrovsky G., Balog J.Z., Huizing M., Hart R.,
RA   Zein W.M., Gahl W.A., Brooks B.P., Adams D.R.;
RT   "DNA variations in oculocutaneous albinism: an updated mutation list
RT   and current outstanding issues in molecular diagnostics.";
RL   Hum. Mutat. 34:827-835(2013).
RN   [43]
RP   VARIANT OCA1A THR-198.
RX   PubMed=24934919; DOI=10.1111/ced.12382;
RA   Shah S.A., Din S.U., Raheem N., Daud S., Mubeen J., Nadeem A.,
RA   Tayyab M., Baloch D.M., Babar M.E., Ahmad J.;
RT   "Identification of a novel mutation (p.Ile198Thr) in gene TYR in a
RT   Pakistani family with nonsyndromic oculocutaneous albinism.";
RL   Clin. Exp. Dermatol. 39:646-648(2014).
CC   -!- FUNCTION: This is a copper-containing oxidase that functions in
CC       the formation of pigments such as melanins and other polyphenolic
CC       compounds. Catalyzes the initial and rate limiting step in the
CC       cascade of reactions leading to melanin production from tyrosine.
CC       In addition to hydroxylating tyrosine to DOPA (3,4-
CC       dihydroxyphenylalanine), also catalyzes the oxidation of DOPA to
CC       DOPA-quinone, and possibly the oxidation of DHI (5,6-
CC       dihydroxyindole) to indole-5,6 quinone.
CC       {ECO:0000250|UniProtKB:P11344}.
CC   -!- CATALYTIC ACTIVITY: 2 L-dopa + O(2) = 2 dopaquinone + 2 H(2)O.
CC       {ECO:0000250|UniProtKB:P11344}.
CC   -!- CATALYTIC ACTIVITY: L-tyrosine + O(2) = dopaquinone + H(2)O.
CC       {ECO:0000250|UniProtKB:P11344}.
CC   -!- COFACTOR:
CC       Name=Cu(2+); Xref=ChEBI:CHEBI:29036;
CC         Evidence={ECO:0000250|UniProtKB:Q9ZP19};
CC       Note=Binds 2 copper ions per subunit.
CC       {ECO:0000250|UniProtKB:Q9ZP19};
CC   -!- SUBCELLULAR LOCATION: Melanosome membrane
CC       {ECO:0000269|PubMed:12643545, ECO:0000269|PubMed:17081065};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:12643545,
CC       ECO:0000269|PubMed:17081065}. Melanosome
CC       {ECO:0000250|UniProtKB:P11344}. Note=Proper trafficking to
CC       melanosome is regulated by SGSM2, ANKRD27, RAB9A, RAB32 and RAB38.
CC       {ECO:0000250|UniProtKB:P11344}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P14679-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P14679-2; Sequence=VSP_006701, VSP_006702;
CC         Note=No experimental confirmation available.;
CC   -!- INDUCTION: Increased expression after UVB irradiation.
CC   -!- PTM: Glycosylated. {ECO:0000250|UniProtKB:P11344}.
CC   -!- POLYMORPHISM: Genetic variants in TYR define the skin/hair/eye
CC       pigmentation variation locus 3 (SHEP3) [MIM:601800]. Hair, eye and
CC       skin pigmentation are among the most visible examples of human
CC       phenotypic variation, with a broad normal range that is subject to
CC       substantial geographic stratification. In the case of skin,
CC       individuals tend to have lighter pigmentation with increasing
CC       distance from the equator. By contrast, the majority of variation
CC       in human eye and hair color is found among individuals of European
CC       ancestry, with most other human populations fixed for brown eyes
CC       and black hair. {ECO:0000269|PubMed:17952075,
CC       ECO:0000269|PubMed:17999355}.
CC   -!- POLYMORPHISM: Compound heterozygosity for the R402Q polymorphism
CC       and a mutant allele of TYR is a common cause of autosomal
CC       recessive ocular albinism. The R402Q polymorphism is also found in
CC       Waardenburg syndrome type II with ocular albinism (WS2-OA) in
CC       association with a deletion in the MITF gene.
CC       {ECO:0000269|PubMed:2342539, ECO:0000269|PubMed:7955413,
CC       ECO:0000269|PubMed:9158138}.
CC   -!- DISEASE: Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]: An
CC       autosomal recessive disorder in which the biosynthesis of melanin
CC       pigment is absent in skin, hair, and eyes. It is characterized by
CC       complete lack of tyrosinase activity due to production of an
CC       inactive enzyme. Patients present with a life-long absence of
CC       melanin pigment after birth, and manifest increased sensitivity to
CC       ultraviolet radiation with predisposition to skin cancer. Visual
CC       anomalies include decreased acuity, nystagmus, strabismus and
CC       photophobia. {ECO:0000269|PubMed:10571953,
CC       ECO:0000269|PubMed:10671066, ECO:0000269|PubMed:10987646,
CC       ECO:0000269|PubMed:11295837, ECO:0000269|PubMed:11858948,
CC       ECO:0000269|PubMed:1487241, ECO:0000269|PubMed:15146472,
CC       ECO:0000269|PubMed:1642278, ECO:0000269|PubMed:1899321,
CC       ECO:0000269|PubMed:1943686, ECO:0000269|PubMed:1970634,
CC       ECO:0000269|PubMed:22981120, ECO:0000269|PubMed:2342539,
CC       ECO:0000269|PubMed:23504663, ECO:0000269|PubMed:24934919,
CC       ECO:0000269|PubMed:7902671, ECO:0000269|PubMed:7955413,
CC       ECO:0000269|PubMed:8128955, ECO:0000269|PubMed:8644824,
CC       ECO:0000269|PubMed:9259202}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Albinism, oculocutaneous, 1B (OCA1B) [MIM:606952]: An
CC       autosomal recessive disorder in which the biosynthesis of melanin
CC       pigment is reduced in skin, hair, and eyes. It is characterized by
CC       partial lack of tyrosinase activity. Patients have white hair at
CC       birth that rapidly turns yellow or blond. They manifest the
CC       development of minimal-to-moderate amounts of cutaneous and ocular
CC       pigment. Some patients may have with white hair in the warmer
CC       areas (scalp and axilla) and progressively darker hair in the
CC       cooler areas (extremities). This variant phenotype is due to a
CC       loss of tyrosinase activity above 35-37 degrees C.
CC       {ECO:0000269|PubMed:10987646, ECO:0000269|PubMed:1900309,
CC       ECO:0000269|PubMed:1903591, ECO:0000269|PubMed:8128955}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the tyrosinase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA61241.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAA68756.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Mutations of the TYR gene; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="http://www.retina-international.org/files/sci-news/tyrmut.htm";
CC   -!- WEB RESOURCE: Name=Albinism database (ADB); Note=TYR mutations;
CC       URL="http://albinismdb.med.umn.edu/oca1mut.html";
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Snowy stardom - Issue
CC       49 of August 2004;
CC       URL="http://web.expasy.org/spotlight/back_issues/049";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Tyrosinase entry;
CC       URL="https://en.wikipedia.org/wiki/Tyrosinase";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TYRID42738ch11q14.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M27160; AAB37227.1; -; mRNA.
DR   EMBL; M63239; AAA61242.1; -; Genomic_DNA.
DR   EMBL; M63235; AAA61242.1; JOINED; Genomic_DNA.
DR   EMBL; M63236; AAA61242.1; JOINED; Genomic_DNA.
DR   EMBL; M63237; AAA61242.1; JOINED; Genomic_DNA.
DR   EMBL; M63238; AAA61242.1; JOINED; Genomic_DNA.
DR   EMBL; J03581; AAA61241.1; ALT_INIT; mRNA.
DR   EMBL; Y00819; CAA68756.1; ALT_INIT; mRNA.
DR   EMBL; U01873; AAB60319.1; ALT_SEQ; mRNA.
DR   EMBL; M74314; AAA61244.1; -; mRNA.
DR   EMBL; X16073; CAA34205.1; -; Genomic_DNA.
DR   EMBL; AF237811; AAK00805.1; -; Genomic_DNA.
DR   EMBL; AF237807; AAK00805.1; JOINED; Genomic_DNA.
DR   EMBL; AF237808; AAK00805.1; JOINED; Genomic_DNA.
DR   EMBL; AF237809; AAK00805.1; JOINED; Genomic_DNA.
DR   EMBL; AF237810; AAK00805.1; JOINED; Genomic_DNA.
DR   EMBL; BC027179; AAH27179.1; -; mRNA.
DR   EMBL; AY012019; AAG38762.1; -; Genomic_DNA.
DR   CCDS; CCDS8284.1; -. [P14679-1]
DR   PIR; A38444; YRHU1.
DR   RefSeq; NP_000363.1; NM_000372.4. [P14679-1]
DR   UniGene; Hs.503555; -.
DR   ProteinModelPortal; P14679; -.
DR   BioGrid; 113150; 1.
DR   STRING; 9606.ENSP00000263321; -.
DR   BindingDB; P14679; -.
DR   ChEMBL; CHEMBL1973; -.
DR   DrugBank; DB00548; Azelaic Acid.
DR   DrugBank; DB09526; Hydroquinone.
DR   DrugBank; DB01055; Mimosine.
DR   DrugBank; DB00600; Monobenzone.
DR   DrugBank; DB00157; NADH.
DR   iPTMnet; P14679; -.
DR   PhosphoSitePlus; P14679; -.
DR   BioMuta; TYR; -.
DR   DMDM; 401235; -.
DR   PaxDb; P14679; -.
DR   PeptideAtlas; P14679; -.
DR   PRIDE; P14679; -.
DR   Ensembl; ENST00000263321; ENSP00000263321; ENSG00000077498. [P14679-1]
DR   GeneID; 7299; -.
DR   KEGG; hsa:7299; -.
DR   UCSC; uc001pcs.4; human. [P14679-1]
DR   CTD; 7299; -.
DR   DisGeNET; 7299; -.
DR   GeneCards; TYR; -.
DR   GeneReviews; TYR; -.
DR   HGNC; HGNC:12442; TYR.
DR   HPA; CAB000079; -.
DR   HPA; HPA043241; -.
DR   HPA; HPA050889; -.
DR   MalaCards; TYR; -.
DR   MIM; 103470; phenotype.
DR   MIM; 203100; phenotype.
DR   MIM; 601800; phenotype.
DR   MIM; 606933; gene.
DR   MIM; 606952; phenotype.
DR   neXtProt; NX_P14679; -.
DR   OpenTargets; ENSG00000077498; -.
DR   Orphanet; 352734; Minimal pigment oculocutaneous albinism type 1.
DR   Orphanet; 352740; Ocular albinism with congenital sensorineural deafness.
DR   Orphanet; 79431; Oculocutaneous albinism type 1A.
DR   Orphanet; 79434; Oculocutaneous albinism type 1B.
DR   Orphanet; 352737; Temperature-sensitive oculocutaneous albinism type 1.
DR   PharmGKB; PA37095; -.
DR   eggNOG; ENOG410IEZU; Eukaryota.
DR   eggNOG; ENOG410Y42I; LUCA.
DR   GeneTree; ENSGT00500000044790; -.
DR   HOVERGEN; HBG003553; -.
DR   InParanoid; P14679; -.
DR   KO; K00505; -.
DR   OMA; EEYNSHQ; -.
DR   OrthoDB; EOG091G03YR; -.
DR   PhylomeDB; P14679; -.
DR   TreeFam; TF315865; -.
DR   BioCyc; MetaCyc:HS01248-MONOMER; -.
DR   BRENDA; 1.14.18.1; 2681.
DR   Reactome; R-HSA-5662702; Melanin biosynthesis.
DR   SABIO-RK; P14679; -.
DR   SIGNOR; P14679; -.
DR   GeneWiki; Tyrosinase; -.
DR   GenomeRNAi; 7299; -.
DR   PRO; PR:P14679; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000077498; -.
DR   CleanEx; HS_TYR; -.
DR   ExpressionAtlas; P14679; baseline and differential.
DR   Genevisible; P14679; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005798; C:Golgi-associated vesicle; TAS:ProtInc.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005764; C:lysosome; TAS:UniProtKB.
DR   GO; GO:0042470; C:melanosome; ISS:UniProtKB.
DR   GO; GO:0033162; C:melanosome membrane; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005507; F:copper ion binding; IMP:UniProtKB.
DR   GO; GO:0004497; F:monooxygenase activity; TAS:Reactome.
DR   GO; GO:0004503; F:monophenol monooxygenase activity; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; IEA:Ensembl.
DR   GO; GO:0006726; P:eye pigment biosynthetic process; TAS:ProtInc.
DR   GO; GO:0042438; P:melanin biosynthetic process; IDA:CACAO.
DR   GO; GO:0006583; P:melanin biosynthetic process from tyrosine; TAS:ProtInc.
DR   GO; GO:0051591; P:response to cAMP; IEA:Ensembl.
DR   GO; GO:0009411; P:response to UV; IEA:Ensembl.
DR   GO; GO:0033280; P:response to vitamin D; IEA:Ensembl.
DR   GO; GO:0048538; P:thymus development; IEA:Ensembl.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   Gene3D; 1.10.1280.10; -; 1.
DR   InterPro; IPR002227; Tyrosinase_Cu-bd.
DR   InterPro; IPR008922; Unchr_di-copper_centre.
DR   Pfam; PF00264; Tyrosinase; 1.
DR   PRINTS; PR00092; TYROSINASE.
DR   SUPFAM; SSF48056; SSF48056; 1.
DR   PROSITE; PS00497; TYROSINASE_1; 1.
DR   PROSITE; PS00498; TYROSINASE_2; 1.
PE   1: Evidence at protein level;
KW   Albinism; Alternative splicing; Complete proteome; Copper; Deafness;
KW   Disease mutation; Glycoprotein; Melanin biosynthesis; Membrane;
KW   Metal-binding; Monooxygenase; Oxidoreductase; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Tumor antigen; Waardenburg syndrome.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19    529       Tyrosinase.
FT                                /FTId=PRO_0000035879.
FT   TOPO_DOM     19    476       Lumenal, melanosome. {ECO:0000255}.
FT   TRANSMEM    477    497       Helical. {ECO:0000255}.
FT   TOPO_DOM    498    529       Cytoplasmic. {ECO:0000255}.
FT   METAL       180    180       Copper A. {ECO:0000250|UniProtKB:Q9ZP19}.
FT   METAL       202    202       Copper A. {ECO:0000250|UniProtKB:Q9ZP19}.
FT   METAL       211    211       Copper A. {ECO:0000250|UniProtKB:Q9ZP19}.
FT   METAL       363    363       Copper B. {ECO:0000250|UniProtKB:Q9ZP19}.
FT   METAL       367    367       Copper B. {ECO:0000250|UniProtKB:Q9ZP19}.
FT   METAL       390    390       Copper B. {ECO:0000250|UniProtKB:Q9ZP19}.
FT   CARBOHYD     86     86       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    111    111       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    161    161       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    230    230       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    337    337       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    371    371       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     346    377       GFASPLTGIADASQSSMHNALHIYMNGTMSQV -> EMGFL
FT                                HVGWAGLKLLTSRDPPPWPPKMLGLQA (in isoform
FT                                2). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_006701.
FT   VAR_SEQ     378    529       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_006702.
FT   VARIANT      19     19       H -> Q (in OCA1A; dbSNP:rs61753177).
FT                                /FTId=VAR_007649.
FT   VARIANT      21     21       P -> S (in OCA1A; dbSNP:rs61753178).
FT                                {ECO:0000269|PubMed:1642278}.
FT                                /FTId=VAR_007650.
FT   VARIANT      36     36       C -> Y (in OCA1A; dbSNP:rs61753179).
FT                                {ECO:0000269|PubMed:10987646}.
FT                                /FTId=VAR_021683.
FT   VARIANT      42     42       D -> G (in OCA1A; dbSNP:rs28940878).
FT                                {ECO:0000269|PubMed:1943686}.
FT                                /FTId=VAR_007651.
FT   VARIANT      44     44       S -> G (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021684.
FT   VARIANT      44     44       S -> R (in OCA1A; dbSNP:rs755700581).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021685.
FT   VARIANT      47     47       G -> D (in OCA1A; dbSNP:rs61753180).
FT                                {ECO:0000269|PubMed:11295837,
FT                                ECO:0000269|PubMed:15146472,
FT                                ECO:0000269|PubMed:8128955}.
FT                                /FTId=VAR_007652.
FT   VARIANT      47     47       G -> V (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021686.
FT   VARIANT      50     50       S -> L (in OCA1A).
FT                                {ECO:0000269|PubMed:23504663}.
FT                                /FTId=VAR_072592.
FT   VARIANT      52     52       R -> I (in OCA1; dbSNP:rs61753182).
FT                                /FTId=VAR_007653.
FT   VARIANT      55     55       C -> Y (in OCA1A; dbSNP:rs28940879).
FT                                {ECO:0000269|PubMed:10571953,
FT                                ECO:0000269|PubMed:1943686}.
FT                                /FTId=VAR_007654.
FT   VARIANT      68     68       Q -> H (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021687.
FT   VARIANT      77     77       R -> Q (in OCA1A; dbSNP:rs61753185).
FT                                {ECO:0000269|PubMed:10987646,
FT                                ECO:0000269|PubMed:11295837,
FT                                ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_007655.
FT   VARIANT      77     77       R -> RR (in OCA1A).
FT                                {ECO:0000269|PubMed:10571953}.
FT                                /FTId=VAR_009236.
FT   VARIANT      77     77       R -> W (in OCA1A; dbSNP:rs61753184).
FT                                {ECO:0000269|PubMed:10987646,
FT                                ECO:0000269|PubMed:23504663}.
FT                                /FTId=VAR_007656.
FT   VARIANT      79     79       S -> L (in OCA1A; dbSNP:rs544053015).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021688.
FT   VARIANT      80     80       W -> R (in OCA1A; dbSNP:rs61753188).
FT                                /FTId=VAR_007657.
FT   VARIANT      81     81       P -> L (in OCA1A; dbSNP:rs28940876).
FT                                {ECO:0000269|PubMed:10987646,
FT                                ECO:0000269|PubMed:15146472,
FT                                ECO:0000269|PubMed:1970634}.
FT                                /FTId=VAR_007658.
FT   VARIANT      89     89       C -> R (in OCA1A; dbSNP:rs28940877).
FT                                {ECO:0000269|PubMed:1899321}.
FT                                /FTId=VAR_007659.
FT   VARIANT      91     91       C -> Y (in OCA1A; dbSNP:rs137854890).
FT                                {ECO:0000269|PubMed:22981120}.
FT                                /FTId=VAR_072593.
FT   VARIANT      97     97       G -> R (in OCA1A; dbSNP:rs61753252).
FT                                {ECO:0000269|PubMed:10987646}.
FT                                /FTId=VAR_007660.
FT   VARIANT     109    109       G -> R (in OCA1A; dbSNP:rs61753253).
FT                                {ECO:0000269|PubMed:11295837}.
FT                                /FTId=VAR_021689.
FT   VARIANT     134    134       F -> C (in dbSNP:rs33955261).
FT                                /FTId=VAR_034576.
FT   VARIANT     142    142       K -> N (in dbSNP:rs11545463).
FT                                /FTId=VAR_042665.
FT   VARIANT     152    152       P -> S (in OCA1B; dbSNP:rs145513733).
FT                                {ECO:0000269|PubMed:8128955}.
FT                                /FTId=VAR_007925.
FT   VARIANT     155    155       T -> S (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021690.
FT   VARIANT     176    176       F -> I (in OCA1A; dbSNP:rs61753259).
FT                                {ECO:0000269|PubMed:1487241}.
FT                                /FTId=VAR_007661.
FT   VARIANT     177    177       V -> F (in OCA1A; dbSNP:rs138487695).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021691.
FT   VARIANT     179    179       M -> L (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021692.
FT   VARIANT     180    180       H -> N (in OCA1A; dbSNP:rs779878377).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021693.
FT   VARIANT     192    192       S -> Y (associated with SHEP3; light/dark
FT                                skin; dbSNP:rs1042602).
FT                                {ECO:0000269|PubMed:10987646,
FT                                ECO:0000269|PubMed:11153699,
FT                                ECO:0000269|PubMed:11214319,
FT                                ECO:0000269|PubMed:15146472,
FT                                ECO:0000269|PubMed:17952075,
FT                                ECO:0000269|PubMed:17999355,
FT                                ECO:0000269|PubMed:2342539}.
FT                                /FTId=VAR_007662.
FT   VARIANT     198    198       I -> T (in OCA1A; dbSNP:rs750553908).
FT                                {ECO:0000269|PubMed:24934919}.
FT                                /FTId=VAR_071756.
FT   VARIANT     199    199       D -> N (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021694.
FT   VARIANT     201    201       A -> S (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021695.
FT   VARIANT     205    205       P -> T (in OCA1A; dbSNP:rs61754362).
FT                                {ECO:0000269|PubMed:11295837}.
FT                                /FTId=VAR_021696.
FT   VARIANT     206    206       A -> T (in OCA1A; dbSNP:rs28940880).
FT                                {ECO:0000269|PubMed:1943686}.
FT                                /FTId=VAR_007663.
FT   VARIANT     216    216       L -> M (in OCA1A; dbSNP:rs61754363).
FT                                /FTId=VAR_007664.
FT   VARIANT     217    217       R -> G (in OCA1A; dbSNP:rs63159160).
FT                                /FTId=VAR_007665.
FT   VARIANT     217    217       R -> Q (in OCA1A; dbSNP:rs61754365).
FT                                {ECO:0000269|PubMed:10987646,
FT                                ECO:0000269|PubMed:1487241}.
FT                                /FTId=VAR_007667.
FT   VARIANT     217    217       R -> S (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021697.
FT   VARIANT     217    217       R -> W (in OCA1A; dbSNP:rs63159160).
FT                                {ECO:0000269|PubMed:10987646,
FT                                ECO:0000269|PubMed:1642278}.
FT                                /FTId=VAR_007666.
FT   VARIANT     217    217       Missing (in OCA1A).
FT                                /FTId=VAR_007926.
FT   VARIANT     227    227       Missing (in OCA1A).
FT                                /FTId=VAR_021698.
FT   VARIANT     236    236       W -> L (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021699.
FT   VARIANT     236    236       W -> S (in OCA1A; dbSNP:rs61754367).
FT                                {ECO:0000269|PubMed:10987646}.
FT                                /FTId=VAR_021700.
FT   VARIANT     239    239       R -> W (in OCA1A; dbSNP:rs774670098).
FT                                {ECO:0000269|PubMed:11858948}.
FT                                /FTId=VAR_021701.
FT   VARIANT     240    240       D -> V (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021702.
FT   VARIANT     243    243       K -> T (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021703.
FT   VARIANT     253    253       G -> R (in OCA1A; dbSNP:rs61754369).
FT                                /FTId=VAR_007668.
FT   VARIANT     256    256       H -> Y (in OCA1A; dbSNP:rs61754370).
FT                                {ECO:0000269|PubMed:11295837,
FT                                ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021704.
FT   VARIANT     272    272       W -> C (in OCA1A; dbSNP:rs62645902).
FT                                {ECO:0000269|PubMed:10987646}.
FT                                /FTId=VAR_021705.
FT   VARIANT     275    275       V -> F (in OCA1B and OCA1A;
FT                                dbSNP:rs104894314).
FT                                {ECO:0000269|PubMed:11295837,
FT                                ECO:0000269|PubMed:1903591,
FT                                ECO:0000269|PubMed:23504663}.
FT                                /FTId=VAR_007669.
FT   VARIANT     288    288       L -> S (in OCA1A).
FT                                /FTId=VAR_007927.
FT   VARIANT     289    289       C -> G (in OCA1A).
FT                                {ECO:0000269|PubMed:10571953}.
FT                                /FTId=VAR_009237.
FT   VARIANT     289    289       C -> R (in OCA1A).
FT                                {ECO:0000269|PubMed:10987646,
FT                                ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_007670.
FT   VARIANT     294    294       E -> G (in OCA1A).
FT                                {ECO:0000269|PubMed:10987646}.
FT                                /FTId=VAR_021706.
FT   VARIANT     294    294       E -> K (in OCA1A and OCA1B;
FT                                dbSNP:rs757754120).
FT                                {ECO:0000269|PubMed:10987646,
FT                                ECO:0000269|PubMed:11295837,
FT                                ECO:0000269|PubMed:8128955}.
FT                                /FTId=VAR_007928.
FT   VARIANT     298    298       R -> W (in OCA1A; dbSNP:rs200854796).
FT                                {ECO:0000269|PubMed:23504663}.
FT                                /FTId=VAR_072594.
FT   VARIANT     299    299       R -> H (in OCA1A; dbSNP:rs61754375).
FT                                {ECO:0000269|PubMed:10571953,
FT                                ECO:0000269|PubMed:1642278,
FT                                ECO:0000269|PubMed:8128955}.
FT                                /FTId=VAR_007671.
FT   VARIANT     299    299       R -> S (in OCA1A; dbSNP:rs61754374).
FT                                {ECO:0000269|PubMed:10571953}.
FT                                /FTId=VAR_007672.
FT   VARIANT     308    308       R -> T (in dbSNP:rs1042608).
FT                                /FTId=VAR_011825.
FT   VARIANT     312    312       L -> V (in OCA1; dbSNP:rs61754377).
FT                                /FTId=VAR_007673.
FT   VARIANT     313    313       P -> R (in OCA1; dbSNP:rs61754378).
FT                                /FTId=VAR_007674.
FT   VARIANT     318    318       V -> E (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021707.
FT   VARIANT     325    325       T -> A (in OCA1B; dbSNP:rs61754379).
FT                                /FTId=VAR_007675.
FT   VARIANT     328    328       E -> Q (in OCA1A; dbSNP:rs61754380).
FT                                {ECO:0000269|PubMed:7902671}.
FT                                /FTId=VAR_007929.
FT   VARIANT     329    329       S -> P (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021708.
FT   VARIANT     332    332       M -> T (in OCA1A; dbSNP:rs372534292).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021709.
FT   VARIANT     339    339       S -> G (in OCA1A; dbSNP:rs62645906).
FT                                {ECO:0000269|PubMed:11295837}.
FT                                /FTId=VAR_007676.
FT   VARIANT     340    340       F -> L (in OCA1; dbSNP:rs62645907).
FT                                /FTId=VAR_007677.
FT   VARIANT     345    345       E -> G (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021710.
FT   VARIANT     346    346       G -> E (in OCA1A; dbSNP:rs773970123).
FT                                /FTId=VAR_007930.
FT   VARIANT     355    355       A -> E (in OCA1A).
FT                                /FTId=VAR_007931.
FT   VARIANT     355    355       A -> P (in OCA1A; dbSNP:rs62645908).
FT                                {ECO:0000269|PubMed:10987646,
FT                                ECO:0000269|PubMed:11295837,
FT                                ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_007678.
FT   VARIANT     355    355       A -> V (in OCA1A; dbSNP:rs151206295).
FT                                {ECO:0000269|PubMed:23504663}.
FT                                /FTId=VAR_072595.
FT   VARIANT     361    361       S -> R (in OCA1A; dbSNP:rs61754383).
FT                                {ECO:0000269|PubMed:8644824}.
FT                                /FTId=VAR_007932.
FT   VARIANT     364    364       N -> H (in OCA1A).
FT                                {ECO:0000269|PubMed:23504663}.
FT                                /FTId=VAR_072596.
FT   VARIANT     367    367       H -> Y (in OCA1A; dbSNP:rs776054795).
FT                                {ECO:0000269|PubMed:7955413}.
FT                                /FTId=VAR_007933.
FT   VARIANT     370    370       M -> T (in OCA1A; dbSNP:rs61754385).
FT                                {ECO:0000269|PubMed:7955413}.
FT                                /FTId=VAR_007934.
FT   VARIANT     371    371       N -> T (in OCA1A; dbSNP:rs61754387).
FT                                /FTId=VAR_007679.
FT   VARIANT     371    371       N -> Y (in OCA1A; dbSNP:rs61754386).
FT                                {ECO:0000269|PubMed:10987646,
FT                                ECO:0000269|PubMed:8644824}.
FT                                /FTId=VAR_007935.
FT   VARIANT     373    373       T -> K (in OCA1A; dbSNP:rs61754388).
FT                                {ECO:0000269|PubMed:10987646,
FT                                ECO:0000269|PubMed:11295837,
FT                                ECO:0000269|PubMed:15146472,
FT                                ECO:0000269|PubMed:2342539,
FT                                ECO:0000269|PubMed:23504663,
FT                                ECO:0000269|PubMed:7955413,
FT                                ECO:0000269|PubMed:8128955}.
FT                                /FTId=VAR_007680.
FT   VARIANT     378    378       Q -> K (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021711.
FT   VARIANT     380    380       S -> P (in OCA1B; dbSNP:rs61754391).
FT                                /FTId=VAR_007681.
FT   VARIANT     382    382       N -> K (in OCA1A; dbSNP:rs104894315).
FT                                /FTId=VAR_007682.
FT   VARIANT     383    383       D -> N (in OCA1A; dbSNP:rs121908011).
FT                                {ECO:0000269|PubMed:11295837,
FT                                ECO:0000269|PubMed:15146472,
FT                                ECO:0000269|PubMed:2342539}.
FT                                /FTId=VAR_007683.
FT   VARIANT     384    384       P -> A (in OCA1A).
FT                                {ECO:0000269|PubMed:23504663}.
FT                                /FTId=VAR_072597.
FT   VARIANT     390    390       H -> D (in OCA1B; dbSNP:rs62645914).
FT                                /FTId=VAR_007684.
FT   VARIANT     393    393       V -> F (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_007936.
FT   VARIANT     395    395       S -> N (in OCA1A; dbSNP:rs752344007).
FT                                /FTId=VAR_007685.
FT   VARIANT     395    395       S -> R (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021712.
FT   VARIANT     398    398       E -> A (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021713.
FT   VARIANT     398    398       E -> V (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021714.
FT   VARIANT     400    400       W -> L (in OCA1A; dbSNP:rs62645916).
FT                                {ECO:0000269|PubMed:10571953}.
FT                                /FTId=VAR_009238.
FT   VARIANT     402    402       R -> G (in OCA1B).
FT                                /FTId=VAR_007937.
FT   VARIANT     402    402       R -> L (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021715.
FT   VARIANT     402    402       R -> Q (in dbSNP:rs1126809).
FT                                {ECO:0000269|PubMed:10987646,
FT                                ECO:0000269|PubMed:15146472,
FT                                ECO:0000269|PubMed:2342539,
FT                                ECO:0000269|PubMed:7955413,
FT                                ECO:0000269|PubMed:9158138}.
FT                                /FTId=VAR_007686.
FT   VARIANT     403    403       R -> S (in OCA1A and OCA1B;
FT                                dbSNP:rs104894316).
FT                                {ECO:0000269|PubMed:10987646,
FT                                ECO:0000269|PubMed:15146472,
FT                                ECO:0000269|PubMed:1642278}.
FT                                /FTId=VAR_007687.
FT   VARIANT     404    404       H -> N (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021716.
FT   VARIANT     404    404       H -> P (in OCA-I; dbSNP:rs62645920).
FT                                /FTId=VAR_007688.
FT   VARIANT     405    405       R -> L (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021717.
FT   VARIANT     406    406       P -> L (in OCA1A and OCA1B;
FT                                dbSNP:rs104894313).
FT                                {ECO:0000269|PubMed:10987646,
FT                                ECO:0000269|PubMed:15146472,
FT                                ECO:0000269|PubMed:1903591}.
FT                                /FTId=VAR_007689.
FT   VARIANT     408    408       Q -> H (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021718.
FT   VARIANT     409    409       E -> D (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021719.
FT   VARIANT     416    416       A -> S (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021720.
FT   VARIANT     417    417       P -> H (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021721.
FT   VARIANT     419    419       G -> R (in OCA1A; dbSNP:rs61754392).
FT                                {ECO:0000269|PubMed:10987646,
FT                                ECO:0000269|PubMed:15146472,
FT                                ECO:0000269|PubMed:1943686,
FT                                ECO:0000269|PubMed:7902671}.
FT                                /FTId=VAR_007690.
FT   VARIANT     422    422       R -> Q (in OCA1A and OCA1B; temperature
FT                                sensitive variant; dbSNP:rs61754393).
FT                                {ECO:0000269|PubMed:10987646,
FT                                ECO:0000269|PubMed:15146472,
FT                                ECO:0000269|PubMed:1900309}.
FT                                /FTId=VAR_007691.
FT   VARIANT     424    424       S -> F (in OCA1A; dbSNP:rs758747581).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021722.
FT   VARIANT     426    426       M -> K (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021723.
FT   VARIANT     427    427       V -> G (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021724.
FT   VARIANT     431    431       P -> L (in OCA1A; dbSNP:rs281865325).
FT                                {ECO:0000269|PubMed:7902671}.
FT                                /FTId=VAR_007938.
FT   VARIANT     434    434       R -> I (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021725.
FT   VARIANT     435    435       N -> D (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021726.
FT   VARIANT     439    439       F -> V (in OCA1A; dbSNP:rs281865327).
FT                                {ECO:0000269|PubMed:10987646}.
FT                                /FTId=VAR_021727.
FT   VARIANT     444    444       D -> G (in OCA1A).
FT                                {ECO:0000269|PubMed:15146472}.
FT                                /FTId=VAR_021728.
FT   VARIANT     446    446       G -> S (in OCA1A; dbSNP:rs104894317).
FT                                {ECO:0000269|PubMed:10987646,
FT                                ECO:0000269|PubMed:11295837,
FT                                ECO:0000269|PubMed:1642278}.
FT                                /FTId=VAR_007692.
FT   VARIANT     448    448       D -> N (in OCA1A; dbSNP:rs104894318).
FT                                {ECO:0000269|PubMed:10987646,
FT                                ECO:0000269|PubMed:15146472,
FT                                ECO:0000269|PubMed:1642278}.
FT                                /FTId=VAR_007693.
FT   VARIANT     490    490       A -> D (in OCA1A).
FT                                {ECO:0000269|PubMed:23504663}.
FT                                /FTId=VAR_072598.
FT   CONFLICT     42     45       DRSP -> TGV (in Ref. 2; AAA61241).
FT                                {ECO:0000305}.
FT   CONFLICT    179    179       M -> I (in Ref. 4; CAA68756).
FT                                {ECO:0000305}.
FT   CONFLICT    373    378       TMSQVQ -> HVPGT (in Ref. 2; AAA61241).
FT                                {ECO:0000305}.
FT   CONFLICT    495    495       L -> P (in Ref. 2; AAA61241/AAA61244).
FT                                {ECO:0000305}.
FT   CONFLICT    520    523       DYHS -> GLPQ (in Ref. 2). {ECO:0000305}.
FT   CONFLICT    525    528       YQSH -> VSEPFIKGLGNRVGPKSPDLTLTQSNVQVPENI
FT                                CWYFL (in Ref. 2). {ECO:0000305}.
SQ   SEQUENCE   529 AA;  60393 MW;  67211A91608A59E1 CRC64;
     MLLAVLYCLL WSFQTSAGHF PRACVSSKNL MEKECCPPWS GDRSPCGQLS GRGSCQNILL
     SNAPLGPQFP FTGVDDRESW PSVFYNRTCQ CSGNFMGFNC GNCKFGFWGP NCTERRLLVR
     RNIFDLSAPE KDKFFAYLTL AKHTISSDYV IPIGTYGQMK NGSTPMFNDI NIYDLFVWMH
     YYVSMDALLG GSEIWRDIDF AHEAPAFLPW HRLFLLRWEQ EIQKLTGDEN FTIPYWDWRD
     AEKCDICTDE YMGGQHPTNP NLLSPASFFS SWQIVCSRLE EYNSHQSLCN GTPEGPLRRN
     PGNHDKSRTP RLPSSADVEF CLSLTQYESG SMDKAANFSF RNTLEGFASP LTGIADASQS
     SMHNALHIYM NGTMSQVQGS ANDPIFLLHH AFVDSIFEQW LRRHRPLQEV YPEANAPIGH
     NRESYMVPFI PLYRNGDFFI SSKDLGYDYS YLQDSDPDSF QDYIKSYLEQ ASRIWSWLLG
     AAMVGAVLTA LLAGLVSLLC RHKRKQLPEE KQPLLMEKED YHSLYQSHL
//
